Blokees представляет более 900 продуктов на выставке 2026 China Toy Expo, продолжая повышать конкурентоспособность продукции

Blokees showcased more than 900 products at the 2026 China Toy Expo, including over 30 first-time product presentations and new offerings tied to global entertainment franchises. As of June 30, 2026, the company reported 559 domestic patents, 25 overseas patents and 85 domestic invention patents. Its BFC creator contest covered 22 countries and regions, as Blokees highlighted continued product innovation and international expansion.

Analysis

The investment signal is product breadth, not demonstrated demand. A large launch slate can improve shelf presence and test which character lines resonate, but it also raises SKU complexity, inventory risk, and the chance that licensing and launch costs outrun sell-through. The key diligence gap is commercial conversion: unit sales, reorder rates, channel inventory, realized pricing, and the economics of licensed versus original-IP products. Patent counts and creator-community reach are inputs, not evidence of defensible pricing power.

Over the next 1–3 months, retailer orders and restocking—not exhibition visibility—are the useful checks. Over 6–18 months, original IP could reduce reliance on external franchises if it generates repeat purchases; otherwise, Blokees remains exposed to licensors’ terms and competition for consumer spend and retail space from established players such as Bandai Namco and Hasbro. Licensors may receive royalties, but the benefit depends on undisclosed contract terms and actual sales.

Contrarian read: the breadth may look like innovation while masking a portfolio-efficiency problem. More launches are positive only if they increase turns and repeat buying without accumulating slow-moving stock. The release provides no independently verifiable financial impact, and the supplied data identifies no investable ticker for Blokees; there is no clear event-driven trade on this announcement alone.

Key Decisions for Investors

• No immediate position based on the exhibit announcement. Treat it as a watch item until sell-through, retailer reorders, and channel inventory are disclosed or corroborated.
• Over the next 1–3 months, monitor evidence of replenishment and product-level demand, especially for newly commercialized franchise lines. Weak reorders or rising inventory would falsify the breadth-as-growth thesis.
• For a 6–18 month reassessment, seek evidence that Hero Infinity or other original IP contributes repeat sales and improves the licensed/original mix; verify licensing economics before treating franchise breadth as a margin opportunity.
• Do not infer a moat from patent totals or creator-contest reach. Revisit only if those inputs translate into repeat purchase, sustained pricing, or lower dependence on third-party IP.